Literature DB >> 16224811

Switching from a restricted to an effective CD4 T cell response by activating CD8+ murine dendritic cells with a Toll-like receptor 9 ligand.

Alexandra Rizzitelli1, David Vremec, Jose A Villadangos, Nasim Mavaddat, Mark D Wright, Ken Shortman.   

Abstract

Freshly isolated quiescent splenic dendritic cell (DC) subtypes differ in their capacity to activate naive CD4 T cells in culture. The CD8+ DC showed a reduced capacity to stimulate T cell proliferation compared to either of the CD8- DC subsets, regardless of antigen and DC dose. In contrast to CD8- DC, the quiescent CD8+ DC did not induce IFN-gamma production from CD4 T cells. The difference between the DC subtypes appeared to be at the level of initial surface molecule interactions, but could not be attributed to differences in expression of MHC class II or B7 family molecules, or to the expression of Fas ligand on DC. However, when activated by inclusion of the Toll-like receptor 9 ligand CpG in culture, CD8+ DC became potent stimulators of both CD4 T cell proliferation and IFN-gamma production. In contrast, similar activation of CD8- DC produced a more modest increase in capacity to stimulate CD4 T cell proliferation and no increase in capacity to stimulate IFN-gamma production. The difference between a quiescent and an activated state is therefore more extreme for CD8+ than for CD8- DC. The especially tight regulation of the activity of CD8+ DC may be essential for the maintenance of self tolerance.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16224811     DOI: 10.1002/eji.200526231

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  5 in total

1.  Vaccinia virus infection of mature dendritic cells results in activation of virus-specific naïve CD8+ T cells: a potential mechanism for direct presentation.

Authors:  Nicole L Yates; Martha A Alexander-Miller
Journal:  Virology       Date:  2006-10-20       Impact factor: 3.616

2.  Rabbit polyclonal mouse antithymocyte globulin administration alters dendritic cell profile and function in NOD mice to suppress diabetogenic responses.

Authors:  Yanfei Huang; Matthew Parker; Changqing Xia; Ruihua Peng; Clive Wasserfall; Tracy Clarke; Lizhen Wu; Tayseer Chowdhry; Martha Campbell-Thompson; John Williams; Michael Clare-Salzler; Mark A Atkinson; Karl L Womer
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

3.  Histone deacetylase inhibition alters dendritic cells to assume a tolerogenic phenotype and ameliorates arthritis in SKG mice.

Authors:  Kenta Misaki; Akio Morinobu; Jun Saegusa; Shimpei Kasagi; Masaaki Fujita; Yoshiaki Miyamoto; Fumichika Matsuki; Shunichi Kumagai
Journal:  Arthritis Res Ther       Date:  2011-05-18       Impact factor: 5.156

4.  Resident CD141 (BDCA3)+ dendritic cells in human skin produce IL-10 and induce regulatory T cells that suppress skin inflammation.

Authors:  Chung-Ching Chu; Niwa Ali; Panagiotis Karagiannis; Paola Di Meglio; Ania Skowera; Luca Napolitano; Guillermo Barinaga; Katarzyna Grys; Ehsan Sharif-Paghaleh; Sophia N Karagiannis; Mark Peakman; Giovanna Lombardi; Frank O Nestle
Journal:  J Exp Med       Date:  2012-04-30       Impact factor: 14.307

Review 5.  The Role of Dendritic Cells During Infections Caused by Highly Prevalent Viruses.

Authors:  Jorge A Soto; Nicolas M S Gálvez; Catalina A Andrade; Gaspar A Pacheco; Karen Bohmwald; Roslye V Berrios; Susan M Bueno; Alexis M Kalergis
Journal:  Front Immunol       Date:  2020-07-16       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.